C92.1Chronic myeloid leukemia, BCR/ABL-positive

C92.1 is the ICD-10-CM diagnosis code for chronic myeloid leukemia, BCR/ABL-positive. It belongs to category C92 (myeloid leukemia), block C81-C96 (malignant neoplasms of lymphoid, hematopoietic and related tissue) and chapter 2 (neoplasms). It is a header code, so it can't be reported by itself; one of its 3 subcodes must be used instead.

Within C92 (myeloid leukemia), C92.1 is specifically for chronic myeloid leukemia, BCR/ABL-positive. Related codes cover acute myeloblastic leukemia (C92.0), atypical chronic myeloid leukemia, BCR/ABL-negative (C92.2), myeloid sarcoma (C92.3), acute promyelocytic leukemia (C92.4), acute myelomonocytic leukemia (C92.5), acute myeloid leukemia with 11q23-abnormality (C92.6), unspecified (C92.9), acute myeloid leukemia with multilineage dysplasia (C92.A) and 1 more.

To report this condition, pick the subcode that matches the documentation: C92.10 (not having achieved remission), C92.11 (in remission) and C92.12 (in relapse).

Don't report C92.1 together with the conditions in its Excludes1 note: atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-), chronic myelomonocytic leukemia (C93.1-) and chronic myeloproliferative disease (D47.1).

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.